X4 Pharmaceuticals Inc logo

X4 Pharmaceuticals Inc

NAS:XFOR (USA)  
$ 0.92 -0.069 (-6.98%) 04:00 PM EST
P/E:
At Loss
P/B:
2.24
Market Cap:
$ 151.30M
Enterprise V:
$ 57.75M
Volume:
2.50M
Avg Vol (2M):
2.20M
Also Trade In:
Volume:
2.50M
Market Cap $:
151.30M
PE Ratio:
At Loss
Avg Vol (2M):
2.20M
Enterprise Value $:
57.75M
PB Ratio:
2.24

Business Description

Description
X4 Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company engaged in the research and development of novel therapeutics for the treatment of rare diseases and those with limited treatment options, with a focus on conditions resulting from dysfunction of the immune system. The Company's lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It has the ability to increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream.
Name Current Vs Industry Vs History
Cash-To-Debt 3.83
Equity-to-Asset 0.39
Debt-to-Equity 0.55
Debt-to-EBITDA -0.29
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 23.52
9-Day RSI 27.9
14-Day RSI 31.18
6-1 Month Momentum % 49.43
12-1 Month Momentum % -23.98

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.64
Quick Ratio 6.64
Cash Ratio 6.35

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -96.1
Shareholder Yield % -86.46

Profitability Rank

Name Current Vs Industry Vs History
ROE % -228.66
ROA % -100.66
ROIC % -264.97
ROC (Joel Greenblatt) % -1515.38
ROCE % -118.17

Financials (Next Earnings Date:2023-11-03 Est.)

XFOR's 30-Y Financials
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:XFOR

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

X4 Pharmaceuticals Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -1.04
Beta 0.57
Volatility % 100.03
14-Day RSI 31.18
14-Day ATR ($) 0.088161
20-Day SMA ($) 1.13257
12-1 Month Momentum % -23.98
52-Week Range ($) 0.65 - 2.575
Shares Outstanding (Mil) 164.42

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

X4 Pharmaceuticals Inc Filings

Filing Date Document Date Form
No Filing Data

X4 Pharmaceuticals Inc Stock Events

Event Date Price($)
No Event Data

X4 Pharmaceuticals Inc Frequently Asked Questions

What is X4 Pharmaceuticals Inc(XFOR)'s stock price today?
The current price of XFOR is $0.92. The 52 week high of XFOR is $2.58 and 52 week low is $0.65.
When is next earnings date of X4 Pharmaceuticals Inc(XFOR)?
The next earnings date of X4 Pharmaceuticals Inc(XFOR) is 2023-11-03 Est..
Does X4 Pharmaceuticals Inc(XFOR) pay dividends? If so, how much?
X4 Pharmaceuticals Inc(XFOR) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1